|
EIF4H expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.061900E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.33380000000294E-06 |
| Normal-vs-Stage2 |
3.055000E-01 |
| Normal-vs-Stage3 |
5.238200E-01 |
| Normal-vs-Stage4 |
6.944000E-01 |
| Stage1-vs-Stage2 |
2.413900E-02 |
| Stage1-vs-Stage3 |
2.578100E-04 |
| Stage1-vs-Stage4 |
5.240600E-04 |
| Stage2-vs-Stage3 |
6.341000E-01 |
| Stage2-vs-Stage4 |
5.329400E-01 |
| Stage3-vs-Stage4 |
8.544800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.020930E-03 |
| Normal-vs-AfricanAmerican |
7.448800E-01 |
| Normal-vs-Asian |
5.514800E-01 |
| Caucasian-vs-AfricanAmerican |
7.079900E-02 |
| Caucasian-vs-Asian |
9.518200E-01 |
| AfricanAmerican-vs-Asian |
4.785200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.273820E-02 |
| Normal-vs-Female |
7.780400E-04 |
| Male-vs-Female |
2.269200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.251230E-01 |
| Normal-vs-Age(41-60Yrs) |
5.401900E-03 |
| Normal-vs-Age(61-80Yrs) |
5.142400E-03 |
| Normal-vs-Age(81-100Yrs) |
7.255000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.198400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.037400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.494800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.773400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.586000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.544600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.7950999999985E-05 |
| Normal-vs-Grade 2 |
3.77220000002954E-06 |
| Normal-vs-Grade 3 |
9.855600E-02 |
| Normal-vs-Grade 4 |
7.889000E-01 |
| Grade 1-vs-Grade 2 |
1.704580E-01 |
| Grade 1-vs-Grade 3 |
1.980070E-02 |
| Grade 1-vs-Grade 4 |
3.745000E-03 |
| Grade 2-vs-Grade 3 |
2.279200E-03 |
| Grade 2-vs-Grade 4 |
1.194610E-04 |
| Grade 3-vs-Grade 4 |
1.196420E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.53840004571515E-09 |
| Normal-vs-ccB subtype |
4.908000E-01 |
| ccA subtype-vs-ccB subtype |
1.45360000036732E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.392410E-02 |
| Normal-vs-N1 |
7.791400E-01 |
| N0-vs-N1 |
1.935810E-01 |
|
|
